Sponsor pipeline

Tessa Therapeutics clinical trial pipeline

Get alerts when Tessa Therapeutics's trials change

3 active trials 0 recruiting 3 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

Active trials by phase

Phase 1
2
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT04268706 Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory… Hodgkin Lymphoma, Adult Active, Not Recruiting 2023-04-05
Phase 1
NCT04526834 Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive… Anaplastic Large Cell Lymphoma Active, Not Recruiting 2023-04-20
NCT05352828 Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of… Classical Hodgkin Lymphoma Active, Not Recruiting 2023-04-03

Disease areas by active trials

Get alerts when Tessa Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free